Comparison between Aristo Bio-Tech IPO and SVS Ventures IPO.
IPO Details
Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while SVS Ventures IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the SVS Ventures IPO is up to ₹10.68 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of SVS Ventures IPO is ₹20.00 per share.
IPO Timetable
Aristo Bio-Tech IPO opens on Jan 16, 2023, while SVS Ventures IPO opens on Dec 30, 2022. The closing date of Aristo Bio-Tech IPO and SVS Ventures IPO is Jan 19, 2023, and Jan 04, 2023, respectively.
| | Aristo Bio-Tech IPO | SVS Ventures IPO |
|---|
| Issue Open | Jan 16, 2023 | Dec 30, 2022 |
| Issue Close | Jan 19, 2023 | Jan 04, 2023 |
| Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 09, 2023 |
| Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 10, 2023 |
| Credit of Share (Tentative) | Jan 27, 2023 | Jan 11, 2023 |
| Listing date (Tentative) | Jan 30, 2023 | Jan 12, 2023 |
Financials & KPIs
Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to SVS Ventures IPO P/E ratio of 75.
Shares Offered
In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in SVS Ventures IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in SVS Ventures IPO.
| | Aristo Bio-Tech IPO | SVS Ventures IPO |
|---|
| Market Maker Reservation | 91,200 shares | 2,82,000 shares |
| NII | 8,60,800 shares | 26,70,000 shares |
| RII | 8,60,800 shares | 26,70,000 shares |
| Total | 17,21,600 shares | 53,40,000 shares |
Bids Received (Subscription)
Aristo Bio-Tech IPO subscribed 217.72x in total, whereas SVS Ventures IPO subscribed 1.27x.
